$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
类风湿关节炎患者服用巴瑞克替尼的临床数据
2025-10-19 11:44:20
Check Details
巴瑞克替尼治疗类风湿关节炎超过两年后的安全性
2025-10-19 11:44:20
Check Details
甲氨蝶吟治疗欠佳的RA患者可服用巴瑞克替尼
2025-10-19 11:44:20
Check Details
巴瑞克替尼治疗类风湿关节炎疗效明显优于甲氨蝶吟
2025-10-19 11:44:20
Check Details
托法替尼类风湿关节炎患者的抑制剂
2025-10-19 11:44:20
Check Details
托法替布类风湿关节炎抑制剂
2025-10-19 11:44:20
Check Details
托法替尼(Tofanib)
2025-10-19 11:44:20
Check Details
托法替尼治疗类风湿性关节炎的疗效
2025-10-19 11:44:20
Check Details
托法替尼治疗类风湿关节炎患者安全有效
2025-10-19 11:44:20
Check Details
托法替尼,类风湿关节炎治疗药物
2025-10-19 11:44:20
Check Details
托法替尼治疗银屑病患者
2025-10-19 11:44:20
Check Details
托法替尼治疗类风湿关节炎的推荐剂量
2025-10-19 11:44:20
Check Details
1
2
...
2635
2636
2637
2638
2639
2640
2641
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
ROS and Cancer: The Potential of Natural Antioxidants
2
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
3
Breaking the Bottleneck: KOSELUGO® (Selumetinib) Reshapes the Treatment Landscape for Neurofibromatosis Type 1 (NF1)
4
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
5
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
6
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
7
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
8
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
9
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
10
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
11
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
12
Adagrasib Medication Management Guide for Special Populations